Silence Therapeutics Plc - American Depository Share - fluxo de caixa (NASDAQ:SLN)

Financials

Cash from operating activities ———-67.64 M-62.27 M -62.27 M Cash from investing activities ———-21.97 M-47.99 M -47.99 M Cash from financing activities ———142.09 M15 K 15 K Free cash flow ———-67.85 M-62.33 M -62.33 M

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

SLN

Financials

Silence Therapeutics Plc - American Depository Share

Notícias

Lucro da Silence Therapeutics superou projeções por $0,11; receita menor do que estimativas

Silence Therapeutics earnings beat by $0.11, revenue fell short of estimates

Jefferies reitera recomendação de compra para Silence Therapeutics antes de divulgação de dados

Jefferies reiterates Buy on Silence Therapeutics stock ahead of data

Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High?

William Blair reitera classificação de ações da Silence Therapeutics pelo potencial do divesiran

William Blair reiterates Silence Therapeutics stock rating on divesiran potential

H.C. Wainwright mantém recomendação de compra para ações da Silence Therapeutics com preço-alvo de US$ 75

H.C. Wainwright reiterates Buy rating on Silence Therapeutics stock at $75

Silence Therapeutics nomeia CFO Rhonda Hellums para o conselho de administração

TreeFrog Therapeutics nomeia Mark Rothera como novo CEO

TreeFrog Therapeutics appoints Mark Rothera as new CEO